Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers

Cardiovascular Research

Volumn 89, Issue 2, 2011, Pages 282-289

  Cheong, Alex ^a   Li, Jing ^a   Sukumar, Piruthivi ^a   Kumar, Bhaskar ^a   Zeng, Fanning ^a   Riches, Kirsten ^a   Munsch, Christopher ^b   Wood, Ian C ^a   Porter, Karen E ^a   Beech, David J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Cell migration; Neointimal hyperplasia; Potassium channels; Vascular smooth muscle cell

Indexed keywords

MARGATOXIN; POTASSIUM CHANNEL KV1.3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IC 50; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; CALCIUM; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FICUSIN; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KV1.3 POTASSIUM CHANNEL; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SAPHENOUS VEIN; SCORPION VENOMS; TIME FACTORS; TRITERPENES; TUNICA INTIMA;

EID: 78751507980     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq305     Document Type: Article

References (45)

1. Owens GK, Kumar MS,Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
2. Angelini GD, Jeremy JY. Towards the treatment of saphenous vein bypass graft failure-a perspective of the Bristol Heart Institute. Biorheology 2002;39:491-499.
3. Mitra AK, Agrawal DK. In stent restenosis: bane of the stent era. J Clin Pathol 2006;59: 232-239.
4. Kumar B, Dreja K, Shah SS, Cheong A, Xu SZ, Sukumar P et al. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res 2006;98:557-563.
5. Beech DJ. Ion channel switching and activation in smooth-muscle cells of occlusive vascular diseases. Biochem Soc Trans 2007;35:890-894.
6. Munaron L, Antoniotti S, Lovisolo D. Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med 2004;8:161-168.
7. Clapham DE. Calcium signaling. Cell 2007;131:1047-1058.
8. Magnier-Gaubil C, Herbert JM, Quarck R, Papp B, Corvazier E, Wuytack F et al. Smooth muscle cell cycle and proliferation. Relationship between calcium influx and sarco-endoplasmic reticulum Ca2+ ATPase regulation. J Biol Chem 1996;271: 27788-27794.
9. Vallot O, Combettes L, Jourdon P, Inamo J, Marty I, Claret M et al. Intracellular Ca2+ handling in vascular smooth muscle cells is affected by proliferation. Arterioscler Thromb Vasc Biol 2000;20:1225-1235.
10. Landsberg JW, Yuan JX. Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation. News Physiol Sci 2004;19:44-50.
11. Gollasch M, Haase H, Ried C, Lindschau C, Morano I, Luft FC et al. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J 1998;12:593-601.
12. Quignard JF, Harricane MC, Menard C, Lory P, Nargeot J, Capron L et al. Transient down-regulation of L-type Ca2+ channel and dystrophin expression after balloon injury in rat aortic cells. Cardiovasc Res 2001;49:177-188.
13. Golovina VA, Platoshyn O, Bailey CL, Wang J, Limsuwan A, Sweeney M et al. Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 2001;280:H746-H755.
14. Berra-Romani R, Mazzocco-Spezzia A, Pulina MV, Golovina VA. Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol 2008;295:C779-C790.
15. Li J, Sukumar P, Milligan CJ, Kumar B, Ma ZY, Munsch CM et al. Interactions, functions, and independence of plasma membrane STIM1 and TRPC1 in vascular smooth muscle cells. Circ Res 2008;103:e97-e104.
16. Baryshnikov SG, Pulina MV, Zulian A, Linde CI, Golovina VA. Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes. Am J Physiol Cell Physiol 2009;297:C1103-C1112.
17. Bisaillon JM, Motiani RK, Gonzalez-Cobos JC, Potier M, Halligan KE, Alzawahra WF et al. Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. Am J Physiol Cell Physiol 2010;298:C993-C1005.
18. Guo RW, Wang H, Gao P, Li MQ, Zeng CY, Yu Y et al. An essential role for stromal interaction molecule 1 in neointima formation following arterial injury. Cardiovasc Res 2009;81:660-668.
19. Beeton C, Chandy KG. Potassium channels, memory T cells, and multiple sclerosis. Neuroscientist 2005;11:550-562.
20. Neylon CB, Lang RJ, Fu Y, Bobik A, Reinhart PH. Molecular cloning and characterization of the intermediate-conductance Ca2+-activated K+ channel in vascular smooth muscle: relationship between KCa channel diversity and smooth muscle cell function. Circ Res 1999;85:e33-e43.
21. Kohler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A et al. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 2003;108:1119-1125.
22. Cheong A, Bingham AJ, Li J, Kumar B, Sukumar P, Munsch C et al. Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol Cell 2005;20:45-52.
23. Si H, Grgic I, Heyken WT, Maier T, Hoyer J, Reusch HP et al. Mitogenic modulation of Ca2+-activated K+ channels in proliferating A7r5 vascular smooth muscle cells. Br J Pharmacol 2006;148:909-917.
24. Tharp DL, Wamhoff BR, Turk JR, Bowles DK. Upregulation of intermediateconductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 2006;291:H2493-H2503.
25. Tharp DL, Wamhoff BR, Wulff H, Raman G, Cheong A, Bowles DK. Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol 2008; 28:1084-1089.
26. George CK, Wulff H, Beeton C, Pennington M, Gutman GA, Cahalan MD. K+ channels as targets for specific immunomodulation. Trends Pharmacol Sci 2004;25: 280-289.
27. Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T et al. Molecular diversity of K+ channels. Ann N Y Acad Sci 1999;868:233-285.
28. Rangaraju S, Chi V, Pennington MW, Chandy KG. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin Ther Targets 2009;13:909-924.
29. Fountain SJ, Cheong A, Flemming R, Mair L, Sivaprasadarao A, Beech DJ. Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle. J Physiol 2004;556:29-42.
30. Madi HA, Riches K,Warburton P, O'Regan DJ, Turner NA, Porter KE. Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients. Am J Physiol Cell Physiol 2009;297:C1307-C1317.
31. Cheong A, Dedman AM, Xu SZ, Beech DJ. KV a1 channels in murine arterioles: differential cellular expression and regulation of diameter. Am J Physiol Heart Circ Physiol 2001;281:H1057-H1065.
32. Garcia-Calvo M, Leonard RJ, Novick J, Stevens SP, Schmalhofer W, Kaczorowski GJ et al. Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J Biol Chem 1993;268:18866-18874.
33. Koo GC, Blake JT, Shah K, Staruch MJ, Dumont F, Wunderler D et al. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. Cell Immunol 1999;197:99-107.
34. Wulff H, Calabresi PA, Allie R, Yun S, Pennington M, Beeton C et al. The voltagegated Kv1.3 K+ channel in effector memory T cells as new target for MS. J Clin Invest 2003;111:1703-1713.
35. Fadool DA, Tucker K, Perkins R, Fasciani G, Thompson RN, Parsons AD et al. Kv1.3 channel gene-targeted deletion produces 'Super-Smeller Mice' with altered glomeruli, interacting scaffolding proteins, and biophysics. Neuron 2004;41:389-404.
36. Vennekamp J, Wulff H, Beeton C, Calabresi PA, Grissmer S, Hansel W et al. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol Pharmacol 2004;65:1364-1374.
37. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995;268:C799-C822.
38. Archer SL, Souil E, Dinh-Xuan AT, Schremmer B, Mercier JC, El Yaagoubi A et al. Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest 1998;101:2319-2330.
39. Chen TT, Luykenaar KD, Walsh EJ, Walsh MP, Cole WC. Key role of Kv1 channels in vasoregulation. Circ Res 2006;99:53-60.
40. Cidad P, Moreno-Dominguez A, Novensa L, Roque M, Barquin L, Heras M et al. Characterization of ion channels involved in the proliferative response of femoral artery smooth muscle cells. Arterioscler Thromb Vasc Biol 2010;30:1203-1211.
41. Moudgil R, Michelakis ED, Archer SL. The role of K+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation 2006;13:615-632.
42. Lin CS, Boltz RC, Blake JT, Nguyen M, Talento A, Fischer PA et al. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med 1993;177:637-645.
43. Kotecha SA, Schlichter LC. A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation. J Neurosci 1999;19:10680-10693.
44. Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez-Marmol R, Sole L et al. Potassium channels: new targets in cancer therapy. Cancer Detect Prev 2006;30: 375-385.
45. Cook KK, Fadool DA. Two adaptor proteins differentially modulate the phosphorylation and biophysics of Kv1.3 ion channel by SRC kinase. J Biol Chem 2002;277: 13268-13280.